NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
1-15 of 398
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
NeuroFrontiersRecognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
NeuroFrontiersUncovering TK2d: How to Navigate Diagnostic Challenges
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
NeuroFrontiersA Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
NeuroFrontiersImproving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Ethan Meltzer, MD
Ethan Meltzer, MD
- advertisement
Implementing Cognitive Screening in MS Care
NeuroFrontiersImplementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Exploring Genetic Links Between EBV Clearance and MS Risk
NeuroFrontiersExploring Genetic Links Between EBV Clearance and MS Risk
David Hafler, MD, FANA, MSc
David Hafler, MD, FANA, MSc
Navigating Emerging Treatment Options in MG
NeuroFrontiersNavigating Emerging Treatment Options in MG
Qihua Fan, MD
Immunologic Phenotyping: The Future of Personalized MG Care
NeuroFrontiersImmunologic Phenotyping: The Future of Personalized MG Care
Shruti Raja, MD, MHS
Shruti Raja, MD, MHS
- advertisement
New Therapies, New Strategy: Rethinking MG Inpatient Care
NeuroFrontiersNew Therapies, New Strategy: Rethinking MG Inpatient Care
Qihua Fan, MD
Qihua Fan, MD
The New Era of Targeted Therapy for Myasthenia Gravis
NeuroFrontiersThe New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
